These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Cerebrospinal fluid in the differential diagnosis of Alzheimer's disease: clinical utility of an extended panel of biomarkers in a specialist cognitive clinic. Paterson RW; Slattery CF; Poole T; Nicholas JM; Magdalinou NK; Toombs J; Chapman MD; Lunn MP; Heslegrave AJ; Foiani MS; Weston PSJ; Keshavan A; Rohrer JD; Rossor MN; Warren JD; Mummery CJ; Blennow K; Fox NC; Zetterberg H; Schott JM Alzheimers Res Ther; 2018 Mar; 10(1):32. PubMed ID: 29558979 [TBL] [Abstract][Full Text] [Related]
6. Associations of Neuropsychiatric Features with Cerebrospinal Fluid Biomarkers of Amyloidogenesis and Neurodegeneration in Dementia with Lewy Bodies Compared with Alzheimer's Disease and Cognitively Healthy People. de Oliveira FF; Miraldo MC; de Castro-Neto EF; de Almeida SS; Matas SLA; Bertolucci PHF; Naffah-Mazzacoratti MDG J Alzheimers Dis; 2021; 81(3):1295-1309. PubMed ID: 33935098 [TBL] [Abstract][Full Text] [Related]
7. The CSF neurofilament light signature in rapidly progressive neurodegenerative dementias. Abu-Rumeileh S; Capellari S; Stanzani-Maserati M; Polischi B; Martinelli P; Caroppo P; Ladogana A; Parchi P Alzheimers Res Ther; 2018 Jan; 10(1):3. PubMed ID: 29368621 [TBL] [Abstract][Full Text] [Related]
8. Association Between Longitudinal Plasma Neurofilament Light and Neurodegeneration in Patients With Alzheimer Disease. Mattsson N; Cullen NC; Andreasson U; Zetterberg H; Blennow K JAMA Neurol; 2019 Jul; 76(7):791-799. PubMed ID: 31009028 [TBL] [Abstract][Full Text] [Related]
9. Moving fluid biomarkers for Alzheimer's disease from research tools to routine clinical diagnostics. Zetterberg H; Blennow K Mol Neurodegener; 2021 Feb; 16(1):10. PubMed ID: 33608044 [TBL] [Abstract][Full Text] [Related]
10. Alzheimer's disease cerebrospinal fluid biomarker in cognitively normal subjects. Toledo JB; Zetterberg H; van Harten AC; Glodzik L; Martinez-Lage P; Bocchio-Chiavetto L; Rami L; Hansson O; Sperling R; Engelborghs S; Osorio RS; Vanderstichele H; Vandijck M; Hampel H; Teipl S; Moghekar A; Albert M; Hu WT; Monge Argilés JA; Gorostidi A; Teunissen CE; De Deyn PP; Hyman BT; Molinuevo JL; Frisoni GB; Linazasoro G; de Leon MJ; van der Flier WM; Scheltens P; Blennow K; Shaw LM; Trojanowski JQ; Brain; 2015 Sep; 138(Pt 9):2701-15. PubMed ID: 26220940 [TBL] [Abstract][Full Text] [Related]
11. Longitudinal structural cerebral changes related to core CSF biomarkers in preclinical Alzheimer's disease: A study of two independent datasets. Falcon C; Tucholka A; Monté-Rubio GC; Cacciaglia R; Operto G; Rami L; Gispert JD; Molinuevo JL; Neuroimage Clin; 2018; 19():190-201. PubMed ID: 30023169 [TBL] [Abstract][Full Text] [Related]
12. The impact of cerebrospinal fluid biomarkers on the diagnosis of Alzheimer's disease. Engelborghs S; Le Bastard N Mol Diagn Ther; 2012 Jun; 16(3):135-41. PubMed ID: 22646065 [TBL] [Abstract][Full Text] [Related]
16. CSF tau and the CSF tau/ABeta ratio for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI). Ritchie C; Smailagic N; Noel-Storr AH; Ukoumunne O; Ladds EC; Martin S Cochrane Database Syst Rev; 2017 Mar; 3(3):CD010803. PubMed ID: 28328043 [TBL] [Abstract][Full Text] [Related]
17. Cerebrospinal fluid biomarkers for diagnosis of Alzheimer's disease: beta-amyloid(1-42), tau, phospho-tau-181 and total protein. Marksteiner J; Hinterhuber H; Humpel C Drugs Today (Barc); 2007 Jun; 43(6):423-31. PubMed ID: 17612711 [TBL] [Abstract][Full Text] [Related]
18. Cerebrospinal fluid in the dementias. Zetterberg H; Rohrer JD; Schott JM Handb Clin Neurol; 2017; 146():85-97. PubMed ID: 29110781 [TBL] [Abstract][Full Text] [Related]
19. Cerebrospinal Fluid Stanniocalcin-1 as a Biomarker for Alzheimer's Disease and Other Neurodegenerative Disorders. Shahim P; Blennow K; Johansson P; Svensson J; Lista S; Hampel H; Andersson LC; Zetterberg H Neuromolecular Med; 2017 Mar; 19(1):154-160. PubMed ID: 27646979 [TBL] [Abstract][Full Text] [Related]
20. How many biomarkers to discriminate neurodegenerative dementia? Sancesario GM; Bernardini S Crit Rev Clin Lab Sci; 2015; 52(6):314-26. PubMed ID: 26292074 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]